CN Patent

CN111718408A — 一种Setmelanotide的制备方法

Assigned to Chengdu Shengnuo Biopharm Co ltd · Expires 2020-09-29 · 6y expired

What this patent protects

本发明提供了一种制备Setmelanotide的方法，方法中采用氨基树脂为起始树脂，按Setmelanotide的氨基序列反相依次接入相应的保护氨基酸得到Setmelanotide肽树脂，Setmelanotide保护肽树脂经酸解后和再经氧化环化后获得Setmelanotide粗品，Setmelanotide粗品再经过纯化和冻干得到Setmelanotide纯品。本发明工艺操作简单，产品总收率高，适合规模化生产。

USPTO Abstract

本发明提供了一种制备Setmelanotide的方法，方法中采用氨基树脂为起始树脂，按Setmelanotide的氨基序列反相依次接入相应的保护氨基酸得到Setmelanotide肽树脂，Setmelanotide保护肽树脂经酸解后和再经氧化环化后获得Setmelanotide粗品，Setmelanotide粗品再经过纯化和冻干得到Setmelanotide纯品。本发明工艺操作简单，产品总收率高，适合规模化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN111718408A
Jurisdiction
CN
Classification
—
Expires
2020-09-29
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Shengnuo Biopharm Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.